{"id":"CHEMBL104943","canonicalSmiles":"NCCO","inchiKey":"HZAXFHJVJLSVMW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MONOETHANOLAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Monoethanolamine","Monoethanolamine oleate"],"crossReferences":{"PubChem":["144213981","17389575"],"Wikipedia":["Ethanolamine"],"drugbank":["DB03994"],"chEBI":["16000"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1086445","canonicalSmiles":"C/C=C/C=O","inchiKey":"MLUCVPSAIODCQM-NSCUHMNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CROTONALDEHYDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Crotonaldehyde"],"crossReferences":{"PubChem":["17389091"],"Wikipedia":["Crotonaldehyde"],"drugbank":["DB04381"],"chEBI":["41607"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1091644","canonicalSmiles":"C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1","inchiKey":"PKCDDUHJAFVJJB-VLZXCDOPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINSITINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-7487","Linsitinib","OSI-906","OSI-906AA"],"crossReferences":{"drugbank":["DB06075"]},"linkedTargets":{"rows":["ENSG00000140443","ENSG00000171105"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0006859","MONDO_0008170","MONDO_0007254","EFO_0003060","EFO_1001951","EFO_1001480","EFO_0000174","MONDO_0002898","EFO_0000182","EFO_0000702","EFO_0000673","EFO_1000796","EFO_0000181"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL1095097","canonicalSmiles":"COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]24CCC(=O)O4)[C@H]13","inchiKey":"JUKPWJGBANNWMW-VWBFHTRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPLERENONE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eplerenone","Inspra"],"synonyms":["Eplerenone","SC-66110","SC-6611O"],"crossReferences":{"DailyMed":["eplerenone"],"PubChem":["144205299","170465283","26754514"],"Wikipedia":["Eplerenone"],"drugbank":["DB00700"],"chEBI":["31547"]},"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["EFO_0004214","EFO_0000275","MONDO_0000153","EFO_0000318","EFO_0000401","EFO_0001645","MONDO_0007254","EFO_0000373","EFO_0000319","EFO_1001461","EFO_0000537","Orphanet_98896","EFO_0000195","EFO_0009784","EFO_0003896","MONDO_0001134","EFO_0008519","EFO_0003144","EFO_0000712","EFO_0003884","EFO_0009363","EFO_0000612","EFO_1001207","MONDO_0005148","EFO_0000400","EFO_1000899"],"count":26},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 6 approved and 10 investigational indications."}
{"id":"CHEMBL109612","canonicalSmiles":"CCCCn1c(Cc2cccc(OC)c2)nc2c(N)ncnc21","inchiKey":"BWLWUGBHOXIUBP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL109612","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03809"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1180004","canonicalSmiles":"CCCCCCCCCCCC[N+](C)(C)C","inchiKey":"VICYBMUVWHJEFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1180004","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02779"],"chEBI":["41378"]},"childChemblIds":["CHEMBL1884887","CHEMBL109873"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1192517","canonicalSmiles":"CNCCCCOc1ccccc1Cc1ccccc1","inchiKey":"QSQQPMHPCBLLGX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIFEMELANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bifemelane","Bifemelane hydrochloride"],"crossReferences":{"PubChem":["11113692","144204477","170465900"],"drugbank":["DB13550"]},"childChemblIds":["CHEMBL543763"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1200331","canonicalSmiles":"C[C@@H]1O[C@@H]1P(=O)(O)O.NC(CO)(CO)CO","inchiKey":"QZJIMDIBFFHQDW-LMLSDSMGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSFOMYCIN TROMETHAMINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1757","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Monuril","Monurol"],"synonyms":["Fosfomycin trometamol","Fosfomycin trometamol (1:1)","Fosfomycin trometamol salt","Fosfomycin tromethamine","Z 1282","Z-1282"],"crossReferences":{"DailyMed":["fosfomycin%20tromethamine"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for urinary tract infection and has 2 investigational indications."}
{"id":"CHEMBL1200522","canonicalSmiles":"COc1ccc(C(=O)CC(=O)c2ccc(C(C)(C)C)cc2)cc1","inchiKey":"XNEFYCZVKIDDMS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVOBENZONE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Parsol 1789"],"synonyms":["Avobenzone","Butyl methoxydibenzoylmethane","Escalol 517","Eusolex 9020","NSC-758680","Neoheliopan 357"],"crossReferences":{"PubChem":["144204980","144209994","170464749","174006249","26748930","93576912"],"Wikipedia":["Avobenzone"],"drugbank":["DB09495"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 3 approved indications."}
{"id":"CHEMBL1200543","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1.O=P(O)(O)O","inchiKey":"FLQCEKVTYABVSH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANILERIDINE PHOSPHATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201347","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Leritine"],"synonyms":["Anileridine phosphate","Leritine phosphate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200649","canonicalSmiles":"CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2CC(=O)[C@H](CS[C@@H]3CN4CCC3CC4)CN2C(=O)[C@H](Cc2ccc(N(C)C)cc2)N(C)C(=O)[C@@H]2CCCN2C1=O","inchiKey":"WTHRRGMBUAHGNI-LCYNINFDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINUPRISTIN","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Quinupristin","RP 57669","RP-57669"],"crossReferences":{"DailyMed":["quinupristin"],"Wikipedia":["Quinupristin"],"drugbank":["DB01369"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1999 and has 1 investigational indication."}
{"id":"CHEMBL1200798","canonicalSmiles":"Cl.O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12","inchiKey":"OHHDIOKRWWOXMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRAZODONE HYDROCHLORIDE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL621","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Desyrel","Molipaxin","Molipaxin cr","Oleptro","Trazodone hydrochloride","Trialodine"],"synonyms":["AF-1161","NSC-292811","Trazodone hcl","Trazodone hydrochloride"],"crossReferences":{"DailyMed":["trazodone%20hydrochloride"],"PubChem":["124891691","144203837","144213002","170465234","26747679","50107085","56423658","855917"],"chEBI":["9655"]},"linkedTargets":{"rows":["ENSG00000108576","ENSG00000102468","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["MONDO_0002050","MONDO_0002009","EFO_0003761","MONDO_0004976"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 3 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200828","canonicalSmiles":"Cl.OC(CCN1CCCCC1)(c1ccccc1)C1CCCC1","inchiKey":"WBCWFMFZMRFRLT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCRIMINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201227","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pagitane"],"synonyms":["Cycrimine HCl","Cycrimine hcl","Cycrimine hydrochloride","NSC-169452"],"crossReferences":{"chEBI":["59693"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200853","canonicalSmiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C","inchiKey":"JGMOKGBVKVMRFX-HQZYFCCVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DYDROGESTERONE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Duphaston","Duphaston-hrt","Gynorest"],"synonyms":["Dydrogesterone","Isopregnenone","NSC-92336"],"crossReferences":{"PubChem":["144203980","170465104","56463092"],"drugbank":["DB00378"],"chEBI":["31527"]},"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0004248","MONDO_0041161","EFO_0000545","EFO_0000731","HP_0000138","MONDO_0014769","EFO_0008560","EFO_1000237","EFO_0003917","EFO_0003922","EFO_0002950","EFO_1000954"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 8 investigational indications."}
{"id":"CHEMBL1200868","canonicalSmiles":"Nc1ccc(C(=O)Oc2ccccc2)c(O)c1","inchiKey":"DNVVZWSVACQWJE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYL AMINOSALICYLATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pheny-pas-tebamin"],"synonyms":["Fenamisal","NSC-40144","Phenyl aminosalicylate"],"crossReferences":{"PubChem":["144205091","170465273","26749950"],"drugbank":["DB06807"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201096","canonicalSmiles":"[81Kr]","inchiKey":"DNNSSWSSYDEUBZ-OIOBTWANSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KRYPTON KR 81M","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1233877","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Krypton kr 81 m gas generator","Mpi krypton 81m generator"],"synonyms":["81mkr","Krypton (81m kr)","Krypton (81mkr)","Krypton (81mkr) gas","Krypton kr 81m","Krypton kr-81m","Krypton, isotope of mass 81","Krypton, kr-81m","Krypton-81m"],"crossReferences":{"drugbank":["DB09443"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1201115","canonicalSmiles":"COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1.Cl","inchiKey":"GEKNCWBANDDJJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESMOLOL HYDROCHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL768","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"year":2007},"tradeNames":["Brevibloc","Esmolol hydrochloride"],"synonyms":["ASL-8052","Esmolol hcl","Esmolol hydrochloride"],"crossReferences":{"DailyMed":["esmolol%20hydrochloride"],"PubChem":["144207045","170465277","49681641"],"chEBI":["4857"]},"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["HP_0100543","EFO_1001459","HP_0000138","EFO_0000537","EFO_0005251"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for hypertension and has 4 investigational indications. It was withdrawn in United States  in 2007."}
{"id":"CHEMBL1201496","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN ASPART","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fiasp","Fiasp flextouch","Fiasp penfill","Ins novorapid","Novolog","Novolog flexpen","Novolog flextouch","Novolog innolet","Novolog penfill"],"synonyms":["B28-ASP-INSULIN","INA-X14","INSULIN X14","Insulin aspart","Insulin aspart recombinant"],"crossReferences":{"DailyMed":["insulin%20aspart","insulin%20aspart%20recombinant"],"DrugCentral":["4981"],"Wikipedia":["Insulin_aspart"]},"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0009543","HP_0003124","EFO_0001645","HP_0002153","Orphanet_586","EFO_0000537","EFO_0000565","EFO_0003914","EFO_0004593","MONDO_0005147","HP_0003074","MONDO_0004975","EFO_0000574","MONDO_0005148","EFO_0000400"],"count":15},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for diabetes mellitus and has 11 investigational indications."}
{"id":"CHEMBL1201544","drugType":"Unknown","blackBoxWarning":true,"name":"IRON DEXTRAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Armidexan","Cosmofer","Dexferrum","Ferran 100","Ferrum","Imferon","Infed","Iron dextran","Nonemic","Proferdex"],"synonyms":["Iron dextran"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201826","drugType":"Enzyme","blackBoxWarning":true,"name":"IDURSULFASE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["EC 3.1.6.13","EC-3.1.6.13","Elaprase","GC1111","Gc-1111","Iduronate-2-sulfatase","Idursulfase","Sulfatase, l-idurono-"],"crossReferences":{"DailyMed":["idursulfase"],"DrugCentral":["4918"],"Wikipedia":["Idursulfase"]},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and is indicated for mucopolysaccharidosis type 2 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201832","drugType":"Protein","blackBoxWarning":false,"name":"ROMIPLOSTIM","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nplate"],"synonyms":["AMG 531","Romiplate","Romiplostim"],"crossReferences":{"DailyMed":["romiplostim"],"DrugCentral":["4996"],"Wikipedia":["Romiplostim"]},"linkedTargets":{"rows":["ENSG00000117400"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","MONDO_0008170","EFO_0000313","HP_0001915","EFO_0005952","MONDO_0018896","HP_0001873","EFO_0000311","MP_0001914","EFO_0007160","Orphanet_906","MONDO_0043768","EFO_0000574","EFO_0000519"],"count":14},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 3 approved and 11 investigational indications."}
{"id":"CHEMBL1207607","canonicalSmiles":"O=S(=O)(O)c1ccc(-c2c3nc(c(-c4ccc(S(=O)(=O)O)cc4)c4ccc([nH]4)c(-c4ccc(S(=O)(=O)O)cc4)c4ccc([nH]4)c(-c4ccc(S(=O)(=O)O)cc4)c4nc2C=C4)C=C3)cc1","inchiKey":"YAVMDSYMZGJNES-LWQDQPMZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRAPHENYLPORPHINE TETRASULFONIC ACID","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-322091","Tetraphenylporphine tetrasulfonic acid"],"childChemblIds":["CHEMBL419460"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL121915","canonicalSmiles":"N[C@@H](Cn1cc(I)c(=O)[nH]c1=O)C(=O)O","inchiKey":"AXXYLTBQIQBTES-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(S)-5-Iodowillardiine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-5-Iodowillardiine"],"crossReferences":{"PubChem":["11113440","50104371"],"Wikipedia":["5-Iodowillardiine"],"drugbank":["DB02818"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231132","canonicalSmiles":"CN(C)C(=O)c1ccc(S(=O)(=O)c2ccc(NC(=O)[C@@](C)(O)C(F)(F)F)c(Cl)c2)cc1","inchiKey":"DTDZLJHKVNTQGZ-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231132","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07403"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231248","canonicalSmiles":"CN1[C@H]2CC[C@@H]1[C@@H](C(=O)O)[C@@H](OC(=O)c1ccccc1)C2","inchiKey":"GVGYEFKIHJTNQZ-RFQIPJPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THERACYS","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206160","144206406"],"drugbank":["DB01515"],"chEBI":["41001"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL123132","canonicalSmiles":"N[C@@H](Cn1cc(F)c(=O)[nH]c1=O)C(=O)O","inchiKey":"DBWPFHJYSTVBCZ-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(S)-5-Fluorowillardiine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-5-Fluorowillardiine","5-Fluorowillardiine"],"crossReferences":{"PubChem":["11113439"],"Wikipedia":["5-Fluorowillardiine"],"drugbank":["DB02966"],"chEBI":["42549"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233464","canonicalSmiles":"O=CCc1ccccc1","inchiKey":"DTUQWGWMVIHBKE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLACETALDEHYDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208780","144213262"],"drugbank":["DB02178"],"chEBI":["16424"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234088","canonicalSmiles":"O=C1Nc2ccccc2/C1=C/Nc1ccc(S(=O)(=O)Nc2nccs2)cc1","inchiKey":"BOMPRXSVSIPRDT-PTNGSMBKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234088","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08125"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234293","canonicalSmiles":"C[n+]1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2nc(N)[nH]c(=O)c21","inchiKey":"OGHAROSJZRTIOK-KQYNXXCUSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234293","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03493"],"chEBI":["20794"]},"childChemblIds":["CHEMBL3351034"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235287","canonicalSmiles":"N[C@H](CO)Cc1ccccc1","inchiKey":"STVVMTBJNDTZBF-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-PHENYLALANINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["93576654"],"drugbank":["DB04484"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237123","canonicalSmiles":"COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC","inchiKey":"GBLRQXKSCRCLBZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXACURIUM","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Doxacurium cation","Doxacurium ion"],"crossReferences":{"drugbank":["DB01135"],"chEBI":["4706"]},"childChemblIds":["CHEMBL1237099"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1991."}
{"id":"CHEMBL127","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12","inchiKey":"DMJNNHOOLUXYBV-PQTSNVLCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEROPENEM","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Meropenem","Merrem","Merrem iv"],"synonyms":["ICI 194,660","ICI-194660","Meronem","Meropenem","Meropenem (as trihydrate)","Meropenem anhydrous","Meropenem hydrate","Meropenem trihydrate","Meropenem, anhydrous","Merrem i.v.","NSC-759621","SM-7338"],"crossReferences":{"DailyMed":["meropenem"],"PubChem":["144204266","170464676","170466350","49681817"],"Wikipedia":["Meropenem"],"drugbank":["DB00760"],"chEBI":["43968"]},"childChemblIds":["CHEMBL4175954"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 7 approved and 15 investigational indications."}
{"id":"CHEMBL1271","canonicalSmiles":"C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1","inchiKey":"XSBSKEQEUFOSDD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTOLINIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ansolysen","Pentolinium","Pentolinium cation","Pentolinium ion","Pentolonium"],"crossReferences":{"Wikipedia":["Pentolinium"],"drugbank":["DB01090"],"chEBI":["347401"]},"childChemblIds":["CHEMBL1356989","CHEMBL118902","CHEMBL1318287"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1289926","canonicalSmiles":"CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1","inchiKey":"RITAVMQDGBJQJZ-FMIVXFBMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AXITINIB","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Inlyta"],"synonyms":["AG-013736","AG-13736","Axitinib","NSC-757441"],"crossReferences":{"DailyMed":["axitinib"],"PubChem":["124950168","144207146","170466656"],"Wikipedia":["Axitinib"],"drugbank":["DB06626"],"chEBI":["66910"]},"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000037280"],"count":3},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003891","EFO_0001065","EFO_0000756","EFO_0000681","EFO_1001465","EFO_1000131","EFO_0004252","EFO_0002890","EFO_0000231","EFO_1001951","MONDO_0001056","EFO_0003860","EFO_0000770","EFO_0000182","EFO_0000673","EFO_0000198","EFO_0000616","EFO_1000508","EFO_0000349","Orphanet_44890","MONDO_0004669","EFO_0000222","EFO_0000313","EFO_0004198","EFO_1001968","MONDO_0016238","EFO_0004243","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_0009708","EFO_0007143","EFO_0000640","EFO_0003865","EFO_0003841","MONDO_0000544","EFO_0002517","MONDO_0011962","EFO_0004142","MONDO_0002367","EFO_1000796","MONDO_0024880","EFO_0000519","EFO_0000181","MONDO_0021640"],"count":46},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 6 approved and 35 investigational indications."}
{"id":"CHEMBL13485","canonicalSmiles":"CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\\C(=O)Nc3ccc(Cl)cc32)c1C","inchiKey":"XPLJEFSRINKZLC-ATVHPVEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SU-11652","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SU-11652"],"crossReferences":{"drugbank":["DB08009"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1371412","canonicalSmiles":"CCCOc1ccc2nc(NC(=O)OC)sc2c1","inchiKey":"HLLICFJUWSZHRJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIOXIDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SCH 21480","SCH-21480","Tioxidazole"],"crossReferences":{"PubChem":["144205396","29216163"],"drugbank":["DB11472"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1399702","canonicalSmiles":"OC[C@H]1O[C@@H](n2cnc3cncnc32)[C@H](O)[C@@H]1O","inchiKey":"MRWXACSTFXYYMV-FDDDBJFASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEBULARINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nebularine"],"crossReferences":{"PubChem":["26753558","50106200","50106201","90340794"],"drugbank":["DB04440"],"chEBI":["18255"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1443","canonicalSmiles":"CCOc1ccc2ccccc2c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12","inchiKey":"GPXLMGHLHQJAGZ-JTDSTZFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAFCILLIN","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Nafcillin","Nallpen","Unipen"],"crossReferences":{"DailyMed":["nafcillin%20sodium"],"Wikipedia":["Nafcillin"],"drugbank":["DB00607"],"chEBI":["7447"]},"childChemblIds":["CHEMBL1200344","CHEMBL1568276"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and is indicated for bacterial disease and infection and has 5 investigational indications."}
{"id":"CHEMBL1451173","canonicalSmiles":"CC(=O)Oc1cccc(C(=O)O)c1OC(C)=O","inchiKey":"NYIZXMGNIUSNKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPYROCETYL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diacetylsalicylic acid","Dipyrocetyl","NSC-758212"],"crossReferences":{"PubChem":["144205057","26749322"],"drugbank":["DB13839"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1487","canonicalSmiles":"CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O","inchiKey":"XUKUURHRXDUEBC-KAYWLYCHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATORVASTATIN","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cardyl","Lipitor","Prevencor","Sortis","Tahor","Zarator"],"synonyms":["Atorvastatin"],"crossReferences":{"DailyMed":["atorvastatin%20calcium"],"PubChem":["124892211","144212734","29215408"],"Wikipedia":["Atorvastatin"],"drugbank":["DB01076"],"chEBI":["39548"]},"childChemblIds":["CHEMBL393220","CHEMBL1790017","CHEMBL3349878"],"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["MONDO_0002492","EFO_0001361","EFO_0000365","MONDO_0001444","EFO_0000275","HP_0001258","EFO_0000681","EFO_0005952","EFO_1000984","EFO_0003914","HP_0100543","EFO_0008585","EFO_0002690","EFO_0009952","EFO_0003884","EFO_0004616","EFO_0000676","EFO_1000961","EFO_0000400","EFO_0000198","MONDO_0013730","EFO_1000812","EFO_0000180","EFO_0004286","EFO_1001771","EFO_0004197","EFO_0000384","EFO_0000660","MONDO_0008315","EFO_0001422","EFO_0009426","EFO_0006818","MONDO_0000831","EFO_0000574","MONDO_0004979","EFO_0007328","EFO_0000341","EFO_0001378","EFO_0005672","EFO_0004214","MONDO_0018373","EFO_0003086","EFO_0001365","HP_0000726","MONDO_0007254","EFO_0008568","EFO_0004252","EFO_0000196","Orphanet_144","EFO_0000616","Orphanet_797","EFO_0000765","EFO_0004269","EFO_0001645","EFO_0003929","EFO_0000222","EFO_0000319","EFO_1001267","EFO_0004911","EFO_0000537","EFO_0000195","EFO_0004517","MONDO_0001134","MONDO_0021661","EFO_0000649","EFO_0000764","Orphanet_79211","MONDO_0011962","MONDO_0005148","EFO_0000519","EFO_0004265","EFO_0004264","EFO_0003869","EFO_0003095","EFO_0000266","EFO_0003913","EFO_0000565","EFO_0007160","EFO_0003870","EFO_0000182","EFO_0004208","EFO_0007243","HP_0003124","EFO_0002687","HP_0001919","EFO_1001466","Orphanet_3389","EFO_0004236","EFO_0004194","Orphanet_413","Orphanet_309005","HP_0002110","HP_0100806","MP_0001845","MONDO_0100096","MONDO_0021187","Orphanet_412","EFO_0000668","Orphanet_232","EFO_0000318","EFO_1001249","MONDO_0002679","EFO_0000373","EFO_0000538","EFO_0004246","EFO_0004211","Orphanet_68380","HP_0000083","EFO_0004247","EFO_0000474","EFO_1001801","EFO_1001375","EFO_0003144","EFO_0000712","EFO_0000673","EFO_1001993","HP_0003119","EFO_0003047","EFO_0007129","EFO_0008586","EFO_0000685","HP_0002140","EFO_0009783","EFO_0000556","HP_0001647","EFO_0002615","EFO_0000311","EFO_0000589","MONDO_0005301","MONDO_0004782","MONDO_0005147","MONDO_0004975","EFO_0008583","EFO_0000612","EFO_0003918"],"count":135},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 14 approved and 97 investigational indications."}
{"id":"CHEMBL157604","canonicalSmiles":"COc1ccc(CC(N)=O)cc1","inchiKey":"OLKQIWCQICCYQS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL157604","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08767"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1615350","canonicalSmiles":"CN(C)CCCC1c2ccccc2Nc2ccc(Cl)cc21","inchiKey":"JFRLWWDJCFYFSU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOMACRAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Hepatotoxicity"],"year":1982},"tradeNames":[],"synonyms":["Clomacran","SKF-14336-D"],"childChemblIds":["CHEMBL2104136"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom  in 1982 due to Hepatotoxicity."}
{"id":"CHEMBL1615807","canonicalSmiles":"CC1(C)C(/C=C/C=C/C=C/C=C2\\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)O)c2ccc3ccccc3c21","inchiKey":"BDBMLMBYCXNVMC-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"INDOCYANINE GREEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB09374"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1616951","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@]2(O)CCC(=O)O","inchiKey":"PBKZPPIHUVSDNM-WNHSNXHDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANRENOATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Canrenoic acid"],"crossReferences":{"drugbank":["DB09015"],"chEBI":["50156"]},"childChemblIds":["CHEMBL1371200"],"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["EFO_0008585","MONDO_0100096","EFO_0000319"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 1 investigational indication."}
{"id":"CHEMBL1651534","canonicalSmiles":"O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1","inchiKey":"BATCTBJIJJEPHM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04457845","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-04457845","Pf-04457845"],"crossReferences":{"Wikipedia":["PF-04457845"],"drugbank":["DB12012"]},"linkedTargets":{"rows":["ENSG00000117480"],"count":1},"linkedDiseases":{"rows":["EFO_0007191","HP_0012532","EFO_0004895","EFO_0004616","EFO_0001358"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1668","canonicalSmiles":"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC","inchiKey":"SZLZWPPUNLXJEA-QEGASFHISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RESCINNAMINE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cinnasil","Moderil"],"synonyms":["Apoterin s","Cartric","Cinnaloid","NSC-15628","Rescinnamine","Rescisan","Resealoid","Reserpinine","Scinnamina","Tsuruselpi s"],"crossReferences":{"PubChem":["56463114"],"Wikipedia":["Rescinnamine"],"chEBI":["28572"]},"linkedTargets":{"rows":["ENSG00000165646"],"count":1},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956 and is indicated for hypertension."}
{"id":"CHEMBL1697775","canonicalSmiles":"OCCSCCCCCCCCCCSCCO","inchiKey":"WRCITXQNXAIKLR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIADENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Delipid","Eulip","Finlipol","Fonlipol","LL 1558","LL-1558","NSC-66316","Thiadenol","Tiadenol","Tiaterol"],"crossReferences":{"drugbank":["DB13348"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1738699","canonicalSmiles":"Cc1cc(C(N)=O)ccc1-n1c(CCC(=O)O)ccc1-c1ccc(-n2ccnc2)cc1","inchiKey":"YVPGZQLRPAGKLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N6022","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-6022","N6022"],"crossReferences":{"drugbank":["DB12206"]},"linkedTargets":{"rows":["ENSG00000197894"],"count":1},"linkedDiseases":{"rows":["Orphanet_586","MONDO_0004979"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743026","drugType":"Antibody","blackBoxWarning":false,"name":"GEVOKIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gevokizumab","VPM-087","VPM087","XOMA 052","XOMA-052"],"linkedTargets":{"rows":["ENSG00000125538"],"count":1},"linkedDiseases":{"rows":["MONDO_0001718","EFO_1001231","EFO_0000685","EFO_0003780","EFO_0009672","MONDO_0005147","HP_0000999","MONDO_0021063","MONDO_0005148","MONDO_0005178","EFO_0003894"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL184618","canonicalSmiles":"NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O","inchiKey":"PGBHMTALBVVCIT-VCIWKGPPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FRAMYCETIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANTIBIOTIQUE EF 185","Actilin","Antibiotic 10676","Dekamycin iii","Enterfram","Fradiomycin b","Framidal","Framycetin","Framycin","Framygen","Francetin","Neomycin b"],"crossReferences":{"DrugCentral":["4247"],"Wikipedia":["Framycetin"],"drugbank":["DB00452"],"chEBI":["7508"]},"childChemblIds":["CHEMBL3188205","CHEMBL1950493"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1922094","canonicalSmiles":"Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12","inchiKey":"YOVVNQKCSKSHKT-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APITOLISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apitolisib","G-038390","G-038390.1","GDC-0980","GDC-0980.1","Gne-390","RG-7422","RG7422","Rg-7422"],"crossReferences":{"drugbank":["DB12180"]},"childChemblIds":["CHEMBL1922103","CHEMBL1922106"],"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["EFO_0000681","MONDO_0007254","EFO_1001512","EFO_0005952","MONDO_0008315","EFO_0000311"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2010872","canonicalSmiles":"CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3","inchiKey":"AEULIVPVIDOLIN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEP-11981","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BOL-303213X","CEP-11981","Cep-11981"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000120156"],"count":4},"linkedDiseases":{"rows":["EFO_0000196","EFO_0000311"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2024517","canonicalSmiles":"CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1.Cl","inchiKey":"GPPJWWMREQHLQT-BHQIMSFRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CARIPRAZINE HYDROCHLORIDE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2028019","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vraylar"],"synonyms":["Cariprazine hcl","Cariprazine hydrochloride","RGH-188 HCL"],"crossReferences":{"DailyMed":["cariprazine%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000149295","ENSG00000151577"],"count":2},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0000289","EFO_0009963"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 3 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2043025","canonicalSmiles":"COc1ccc2c(c1)C=C1Cn3c-2c(C2CCCCC2)c2ccc(cc23)C(=O)NS(=O)(=O)N(C)CCOCCN(C)C1=O","inchiKey":"UOBYJVFBFSLCTQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TMC-647055","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TMC647055","Tmc-647055"],"crossReferences":{"drugbank":["DB11822"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2070241","canonicalSmiles":"CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O","inchiKey":"FFHBJDQSGDNCIV-MFVUMRCOSA-N","drugType":"Protein","blackBoxWarning":false,"name":"BREMELANOTIDE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bremelanotide"],"synonyms":["Bremelanotide","PT-141","PT-141 FREE BASE"],"crossReferences":{"drugbank":["DB11653"]},"childChemblIds":["CHEMBL4297533"],"linkedTargets":{"rows":["ENSG00000166603"],"count":1},"linkedDiseases":{"rows":["EFO_0004714","EFO_0000677","HP_0002018"],"count":3},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for sexual dysfunction and mental or behavioural disorder and has 2 investigational indications."}
{"id":"CHEMBL2103839","canonicalSmiles":"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C","inchiKey":"BUROJSBIWGDYCN-GAUTUEMISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIDAFOROLIMUS","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AP 23573","AP-23573","AP23573","Deforolimus","MK-8669","Ridaforolimus"],"crossReferences":{"drugbank":["DB06233"],"chEBI":["79700"]},"linkedTargets":{"rows":["ENSG00000198793"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0003869","EFO_0000637","EFO_1001465","MONDO_0007254","EFO_1001968","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_0000565","EFO_0002430","EFO_0000564","MONDO_0011962","EFO_0000574","EFO_0001378","EFO_0000691","EFO_0000569","MONDO_0021054"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 19 investigational indications."}
{"id":"CHEMBL2104678","canonicalSmiles":"CCN(CC)C(=O)CSc1ccc(Cl)nn1","inchiKey":"SSLKKMZJCJBOML-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZINTAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azintamide","Azinthiamide","Colerin","NSC-291837","ST 9067","ST-9067"],"crossReferences":{"drugbank":["DB13992"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105160","canonicalSmiles":"C[C@@H](N/C(=N\\C#N)Nc1ccc(C#N)cc1)C(C)(C)C","inchiKey":"PGYDRGZVXVVZQC-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAMINIDIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-234303","BMS-234303-01","Naminidil","Naminidil, (r)-"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106409","canonicalSmiles":"CO[C@H]1[C@@H](O)[C@@H](C)O[C@H](O[C@H]2[C@H](Oc3cccc4c(O)c5c(=O)oc6ccc(C)c7c(=O)oc(c34)c5c67)O[C@H](C)[C@H](O)[C@]2(C)O)[C@@H]1N","inchiKey":"MGQRRMONVLMKJL-KWJIQSIXSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"ELSAMITRUCIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BBM-2478A","BMY-28090","Elsamitrucin","NSC-369327"],"crossReferences":{"drugbank":["DB05129"]},"description":"Oligosaccharide drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2107546","canonicalSmiles":"CC(C)(Cc1c[nH]c2ccccc12)NCC(O)COc1ccccc1C#N.Cl","inchiKey":"NCEAPFRHADKEHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUCINDOLOL HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL321582","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bucindolol hcl","Bucindolol hydrochloride","Gencaro","MJ 13,105-1","MJ-13105-1"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000043591"],"count":5},"linkedDiseases":{"rows":["EFO_0000275"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107778","canonicalSmiles":"C=C1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]2(C)[C@@]1(O)C(C)=O","inchiKey":"SFLXYFZGKSGFKA-XUDSTZEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEGESTERONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Nestorone"],"synonyms":["Segesterone"],"crossReferences":{"drugbank":["DB14584"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107845","drugType":"Cell","blackBoxWarning":false,"name":"CARLECORTEMCEL-L","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Stemex"],"synonyms":["Carlecortemcel-l"],"description":"Cell drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108297","drugType":"Enzyme","blackBoxWarning":false,"name":"BUCELIPASE ALFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bucelipase alfa"],"description":"Enzyme drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108341","drugType":"Antibody","blackBoxWarning":false,"name":"SONTUZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS-1402","HUHMFG-1","Sontuzumab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108616","drugType":"Antibody","blackBoxWarning":false,"name":"LIBIVIRUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hepex-b"],"synonyms":["Libivirumab"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108822","drugType":"Unknown","blackBoxWarning":false,"name":"TYPHOID VACCINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bacillus typhi","Salmonella choleraesuis typhi","Salmonella enterica ser. typhi","Salmonella typhi","Salmonella typhimurium","Salmonella typhosa","Typhoid vaccine","Typhoid vaccine antigens","Vaccines, typhoid"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109214","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPAGERMANIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-267004","Propagermanium"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109346","drugType":"Antibody","blackBoxWarning":false,"name":"AME-133V","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AME-133V","LY-2469298"],"linkedTargets":{"rows":["ENSG00000160255"],"count":1},"linkedDiseases":{"rows":["EFO_0005952"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109428","drugType":"Antibody","blackBoxWarning":false,"name":"TRX-518","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TRX-518","Trx-518"],"linkedTargets":{"rows":["ENSG00000186891"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000756","MONDO_0008170","MONDO_0007254","MONDO_0008315"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2109478","drugType":"Antibody","blackBoxWarning":false,"name":"DAPIROLIZUMAB PEGOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDP-7657","CDP7657","Cdp-7657","Dapirolizumab pegol"],"linkedTargets":{"rows":["ENSG00000102245"],"count":1},"linkedDiseases":{"rows":["EFO_0002690"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109616","drugType":"Antibody","blackBoxWarning":false,"name":"ABX-IL8","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABX-IL8","Abx-il8"],"linkedTargets":{"rows":["ENSG00000169429"],"count":1},"linkedDiseases":{"rows":["EFO_0006505"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109649","drugType":"Antibody","blackBoxWarning":false,"name":"RG-7594","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RG-7594"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2111051","canonicalSmiles":"C#CCO[C@H]1CN2CCC1CC2","inchiKey":"XVFJONKUSLSKSW-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALSACLIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Talsaclidine"],"crossReferences":{"drugbank":["DB12287"]},"childChemblIds":["CHEMBL2107204"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072","ENSG00000168539"],"count":3},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL214502","canonicalSmiles":"O=C(O)COc1c(C(=O)O)sc(-c2ccc(O)cc2)c1Br","inchiKey":"QZWUMLLRAVGBHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL214502","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07197"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2165224","canonicalSmiles":"CN1[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@@H](O)C2","inchiKey":"WTQYWNWRJNXDEG-RBZJEDDUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANISODAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-6.beta.-hydroxyhyoscyamine","6.beta.-hydroxyhyoscyamine","Anisodamine","Hyoscyamine, 6-hydroxy-"],"crossReferences":{"drugbank":["DB11785"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL219410","canonicalSmiles":"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@H](n3cnnn3)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C","inchiKey":"CGTADGCBEXYWNE-JUKNQOCSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOTAROLIMUS","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-578","Mdt-4107","Zotarolimus"],"linkedTargets":{"rows":["ENSG00000088832"],"count":1},"linkedDiseases":{"rows":["EFO_0001645"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2218885","canonicalSmiles":"C=Cc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CCC(=O)O)c(CCC(=O)OC)c4C)C1(C)C3=CC=C(C(=O)OC)C1C(=O)OC.C=Cc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CCC(=O)OC)c(CCC(=O)O)c4C)C1(C)C3=CC=C(C(=O)OC)C1C(=O)OC","inchiKey":"NJLRKAMQPVVOIU-IXZGEAKMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERTEPORFIN","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Visudyne"],"synonyms":["Bpd-ma","CL 318,952","CL-318952","Verteporfin"],"crossReferences":{"DailyMed":["verteporfin"],"DrugCentral":["2816"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for wet macular degeneration and ocular vascular disease and has 13 investigational indications."}
{"id":"CHEMBL221959","canonicalSmiles":"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12","inchiKey":"UJLAWZDWDVHWOW-YPMHNXCESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOFACITINIB","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["550","CP 690550","CP- 690 550","CP-690","CP-690,550","CP-690,550 FREE BASE","CP-690-550","CP-690550","CP-690550 FREE BASE","CP690,550","CP690550","Cp-690 free base","Tasocitinib","Tofacitinib"],"crossReferences":{"DailyMed":["tofacitinib%20citrate"],"PubChem":["124939204","50100095"],"Wikipedia":["Tofacitinib"],"drugbank":["DB08895"],"chEBI":["71200"]},"childChemblIds":["CHEMBL2103743"],"linkedTargets":{"rows":["ENSG00000096968","ENSG00000162434","ENSG00000105639","ENSG00000105397"],"count":4},"linkedDiseases":{"rows":["EFO_0000729","EFO_0003086","EFO_1001494","EFO_0003778","EFO_0000274","EFO_0000540","EFO_0008518","EFO_0002690","EFO_0003884","EFO_0000676","EFO_0004991","EFO_0000717","Orphanet_379","EFO_0003921","Orphanet_797","EFO_0000685","EFO_1001857","EFO_1000636","EFO_1000906","EFO_0003898","MONDO_0019558","EFO_0000384","EFO_0002609","EFO_0003106","EFO_0003834","EFO_0000546","MONDO_0100096","EFO_0004192","EFO_0000398","EFO_0005297","MONDO_0019472","EFO_0000699","EFO_0003872"],"count":33},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 3 approved and 29 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL227924","canonicalSmiles":"NC[C@@H](c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1","inchiKey":"HWVGILTYGZFGLR-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL227924","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07857"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL251932","canonicalSmiles":"Oc1c(Br)cc(-c2nc3ccccc3o2)cc1Br","inchiKey":"DMOJYCAJRLAKQW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL251932","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08206"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL254316","canonicalSmiles":"Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1","inchiKey":"CZFFBEXEKNGXKS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RALTEGRAVIR","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Isentress"],"synonyms":["MK-0518","Raltegravir"],"crossReferences":{"DailyMed":["raltegravir%20potassium"],"PubChem":["124896574","170466888"],"Wikipedia":["Raltegravir"],"drugbank":["DB06817"]},"childChemblIds":["CHEMBL1162988","CHEMBL518520","CHEMBL4567874","CHEMBL460566"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 4 approved and 11 investigational indications."}
{"id":"CHEMBL257662","canonicalSmiles":"COc1cc2c(c(OC)c1OC)-c1ccc(OP(=O)(O)O)cc1[C@@H](NC(C)=O)CC2","inchiKey":"UGBMEXLBFDAOGL-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZD-6126","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANG 453","ANG-453","AZD 6126","AZD-6126","ZD 6126","ZD-6126","ZM 445526","ZM-445526","Zd-6126","Zd6126"],"crossReferences":{"drugbank":["DB11872"]},"childChemblIds":["CHEMBL4067484"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL273348","canonicalSmiles":"NC1CCN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1","inchiKey":"WUWFMDMBOJLQIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOSUFLOXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A 61827","A 67107","A-61827","A-67107","ABBOTT 61827","ABBOTT-61827","Ozex","Tosufloxacin","Tosufloxacin tosilate"],"crossReferences":{"PubChem":["124893342","50112789"],"Wikipedia":["Tosufloxacin"],"chEBI":["77581"]},"childChemblIds":["CHEMBL542832","CHEMBL104270"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL278894","canonicalSmiles":"CC(C)(C)Nc1nc(C(F)(F)F)nc2ccc(-c3cccc(N)c3)cc12","inchiKey":"XQKJVNGGVLHNLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL278894","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07612"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL282686","canonicalSmiles":"CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(=O)O","inchiKey":"CXGTZJYQWSUFET-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TESAGLITAZAR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Galida"],"synonyms":["AR-H-039242","AR-H039242XX","AZ-242","Az-242","BR-44608","Tesaglitazar"],"crossReferences":{"drugbank":["DB06536"]},"linkedTargets":{"rows":["ENSG00000186951","ENSG00000132170"],"count":2},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL290744","canonicalSmiles":"C[C@H](CC(=O)O)[C@H](N)C(=O)O","inchiKey":"FHJNAFIJPFGZRI-WUJLRWPWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL290744","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03810"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL293405","canonicalSmiles":"Cc1ncnc2nc[nH]c12","inchiKey":"SYMHUEFSSMBHJA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL293405","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124899121"],"drugbank":["DB02113"],"chEBI":["40274"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL294029","canonicalSmiles":"C[C@@H](c1nc(-c2ccc(C#N)cc2)cs1)[C@](O)(Cn1cncn1)c1ccc(F)cc1F","inchiKey":"OPAHEYNNJWPQPX-RCDICMHDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAVUCONAZOLE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-207147","ER-30346","Ravuconazole"],"crossReferences":{"Wikipedia":["Ravuconazole"],"drugbank":["DB06440"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL296306","canonicalSmiles":"OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"JCQLYHFGKNRPGE-FCVZTGTOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LACTULOSE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acilac","Bifiteral","Cephulac","Cholac","Chronulac","Constilac","Constulose","Duphalac","Duphalac dry","Enulose","Evalose","Generlac","Heptalac","Lactulose","Laxilose","Laxose orange","Lemlax","Osmolax","Portalac","Regulose"],"synonyms":["4-galactosyl fructose","E966","Lactulose","Lactulose jp17","NSC-757082"],"crossReferences":{"DailyMed":["lactulose"],"PubChem":["144204871","170464861","26754430"],"Wikipedia":["Lactulose"],"drugbank":["DB00581"],"chEBI":["6359"]},"childChemblIds":["CHEMBL1237068"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and is indicated for constipation disorder and constipation and has 3 investigational indications."}
{"id":"CHEMBL309282","canonicalSmiles":"CC1(C)CCC(C)(C)c2cc(C(=O)c3ccc4cc(C(=O)O)ccc4c3)ccc21","inchiKey":"RWYREGSYPCNZTL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL309282","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02741"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL315985","canonicalSmiles":"NC(=O)N1c2ccccc2C[C@H](O)c2ccccc21","inchiKey":"BMPDWHIDQYTSHX-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESLICARBAZEPINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Erelib","Pazzul","Stedesa"],"synonyms":["(s)-licarbazepine","BIA 2-194","BIA-2-194","CGP-13751","Eslicarbazepine","Licarbazepine, (s)-"],"crossReferences":{"drugbank":["DB14575"]},"linkedTargets":{"rows":["ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0000474"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for epilepsy."}
{"id":"CHEMBL3182813","canonicalSmiles":"CCN(CC)C(=S)[S-].CCN(CC)C(=S)[S-].[Zn+2]","inchiKey":"RKQOSDAEEGPRER-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3182813","maximumClinicalTrialPhase":0,"parentId":"CHEMBL961","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207461"],"drugbank":["DB14193"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3184437","canonicalSmiles":"OCc1ccc(Cl)cc1Cl","inchiKey":"DBHODFSFBXJZNY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICHLOROBENZYL ALCOHOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dichlorobenzyl alcohol","Dybenal","NSC-15635","Oxiconazole related compound d","Rapidosept"],"crossReferences":{"PubChem":["144211212","170465574"],"drugbank":["DB13269"],"chEBI":["48220"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3186475","canonicalSmiles":"CC(O)CCO","inchiKey":"PUPZLCDOIYMWBV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3186475","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144209606","144210405"],"drugbank":["DB14110"],"chEBI":["52683"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3186492","canonicalSmiles":"Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O.Cl.O.O","inchiKey":"VRSLTNZJOUZKLX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ONDANSETRON HYDROCHLORIDE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL46","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Demorem","Ondansetron hydrochloride","Ondansetron hydrochloride preservative free","Ondemet","Setofilm","Zofran","Zofran preservative free"],"synonyms":["GR 38032F","GR-38032F","NSC-665799","Odansetron hydrochloride","Ondansetron (as hydrochloride)","Ondansetron hcl","Ondansetron hydrochloride","Ondansetron hydrochloride dihydrate","Ondansetron hydrochloride hydrate","Ondansetron monohydrochloride","SN 307","SN-307","Zophren"],"crossReferences":{"DailyMed":["ondansetron%20hydrochloride"],"PubChem":["144206896"]},"linkedTargets":{"rows":["ENSG00000166736"],"count":1},"linkedDiseases":{"rows":["EFO_0006911","Orphanet_79292","EFO_0011023","EFO_0004888","HP_0002013","EFO_0005611","EFO_0003843","HP_0002018","EFO_0007386"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 4 approved and 4 investigational indications."}
{"id":"CHEMBL3219143","canonicalSmiles":"COc1cc(F)ccc1Cn1ccc2c3c(ncc21)C(=O)N(O)CC3","inchiKey":"OYKZKGBMHATGTA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04776548","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-04776548","PF-4776548","Pf-04776548"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3251336","canonicalSmiles":"O=c1ccn2c(n1)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]12","inchiKey":"UUGITDASWNOAGG-CCXZUQQUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3251336","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04627"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL351298","canonicalSmiles":"N=C(N)c1cccc(CN2CCN(S(=O)(=O)c3cc4ccc(Cl)cc4s3)CC2=O)c1","inchiKey":"PRMSFVUWLBPPLY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL351298","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08487"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545013","drugType":"Small molecule","blackBoxWarning":false,"name":"APN1125","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apn1125"],"linkedTargets":{"rows":["ENSG00000175344"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545121","drugType":"Small molecule","blackBoxWarning":false,"name":"EPITINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epitinib","HMPL-813","Hmpl-813"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000519"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545290","drugType":"Small molecule","blackBoxWarning":false,"name":"PRS-211375","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cannabinor","Cannabinor, (-)-","PRS-211,375","Prs-211375"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL357995","canonicalSmiles":"Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1","inchiKey":"UUOJIACWOAYWEZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BOPINDOLOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bopindolol","Bopindolol malonate"],"crossReferences":{"PubChem":["144205570","170466106","26756519"],"Wikipedia":["Bopindolol"],"drugbank":["DB08807"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3581693","canonicalSmiles":"CC/C(=C(/c1ccc(/C=C/C(=O)O)cc1)c1ccc2[nH]ncc2c1)c1ccc(F)cc1Cl","inchiKey":"BURHGPHDEVGCEZ-KJGLQBJMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRILANESTRANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARN-810","Brilanestrant","GDC-0810","Gdc-0810","RG-6046","RG6046"],"crossReferences":{"drugbank":["DB12253"]},"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL361497","canonicalSmiles":"C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(=O)O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4","inchiKey":"FIHJKUPKCHIPAT-AHIGJZGOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARTESUNATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arsumax"],"synonyms":[".alpha.-artesunic acid","Artesunate","Artesunatum","Artesunic acid","Dihydroqinghaosu hemisuccinate","LJPC-0118","NSC-712571","Plasmotrin","Qinghaozhi","Saphnate","Zysunate"],"crossReferences":{"drugbank":["DB09274"],"chEBI":["63918"]},"childChemblIds":["CHEMBL207675"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for malaria and has 13 investigational indications."}
{"id":"CHEMBL3707379","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04958242","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB-104","PF-04958242","PF-4958242","Pf-04958242"],"linkedTargets":{"rows":["ENSG00000125675","ENSG00000120251","ENSG00000155511","ENSG00000152578"],"count":4},"linkedDiseases":{"rows":["MONDO_0005090","EFO_1001176"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3753858","canonicalSmiles":"c1cc(-c2nc3ccc(-c4ccc5nc(-c6ccncc6)[nH]c5c4)cc3[nH]2)ccn1","inchiKey":"UHQFBTAJFNVZIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIDINILAZOLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ridinilazole","SMT-19969","SMT19969","Smt19969"],"crossReferences":{"drugbank":["DB15308"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL379300","canonicalSmiles":"Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12","inchiKey":"YWTBGJGMTBHQTM-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"A-443654","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-443654","A-4436554"],"crossReferences":{"PubChem":["81066752"],"drugbank":["DB08073"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL380394","canonicalSmiles":"O=C(O)c1c(NS(=O)(=O)c2ccccc2)ccc2c1CCCC2","inchiKey":"RRXVUYHFDBLTEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL380394","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07322"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL391640","canonicalSmiles":"C/C(=C\\S(=O)(=O)N[C@H]1CCN([C@@H](C)C(=O)N2CCOCC2)C1=O)c1ccc(Cl)s1","inchiKey":"YMJHMJLNQLVUAV-GHYUOPHCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL391640","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07211"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL397647","canonicalSmiles":"C[N+](C)(Cc1ccc(NC(=O)c2ccc(Cl)c(Cl)c2)cc1)C1CCOCC1","inchiKey":"BXCVNDLGUWFNBK-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-17166864","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4297292"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3989866","canonicalSmiles":"O=C(NCc1c(F)cc(F)cc1F)c1cn2c(c(O)c1=O)C(=O)N1[C@H]3CC[C@H](C3)O[C@@H]1C2","inchiKey":"SOLUWJRYJLAZCX-LYOVBCGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BICTEGRAVIR","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bictegravir","GS-9883","GS-9883-01"],"crossReferences":{"DailyMed":["bictegravir%20sodium"],"drugbank":["DB11799"]},"childChemblIds":["CHEMBL3989867"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for hiv-1 infection and has 3 investigational indications."}
{"id":"CHEMBL3989979","drugType":"Cell","blackBoxWarning":false,"name":"RIVOGENLECLEUCEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BPX-501","Rivogenlecleucel"],"description":"Cell drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4071864","canonicalSmiles":"CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21","inchiKey":"LYPAFUINURXJSG-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK2982772","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gsk2982772"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4105630","canonicalSmiles":"C[C@]12CC[C@@H]3[C@H]4CC[C@@](C)(O)C[C@H]4CC[C@H]3[C@@H]1CC[C@@H]2C(=O)Cn1cc(C#N)cn1","inchiKey":"HARRKNSQXBRBGZ-GVKWWOCJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZURANOLONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["S-812217","SAGE-217","SGE-797","Sage-217","Zuranolone"],"crossReferences":{"drugbank":["DB15490"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL427342","canonicalSmiles":"O=C(Nc1cccc(C2=NCCN2)c1)Nc1cccc(C2=NCCN2)c1","inchiKey":"SCEVFJUWLLRELN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMIDOCARB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imidocarb","Imizol","MMV665810","TCMDC-124304"],"crossReferences":{"drugbank":["DB11521"],"chEBI":["51804"]},"childChemblIds":["CHEMBL590893","CHEMBL1315701","CHEMBL3989411","CHEMBL1362780"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL428462","canonicalSmiles":"Clc1ccc(C2(c3ccc(-c4cn[nH]c4)cc3)CCNCC2)cc1","inchiKey":"LZMOSYUFVYJEPY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL428462","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07859"],"chEBI":["82708"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297337","canonicalSmiles":"[11CH3]OCc1cccnc1N1CCN(C[C@H]2COc3ccccc3O2)CC1","inchiKey":"VGIYMYGMVXPMKV-GWDMYEQXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORM-13070 C-11","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4302506","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(11C)ORM-13070","11C-ORM-13070","11c-orm-13070","Orm-13070 c-11"],"crossReferences":{"drugbank":["DB15324"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297359","canonicalSmiles":"COc1c(C)cnc(Cn2cc(C#CCCOP(=O)(O)O)c3c(Cl)nc(N)nc32)c1C","inchiKey":"BMZGPNGECPQAGB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIIB-028","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB028","Biib-028","Biib028"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297393","canonicalSmiles":"C/C1=C/C[C@@H](/C(C)=C/c2cc(C)on2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)/C=C\\C1","inchiKey":"JAYGOFBXDFAXBW-CYEKYUJNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KOSN-1724","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iso-fludelone","Kosn-1724"],"crossReferences":{"drugbank":["DB13078"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297468","canonicalSmiles":"COc1ccc([C@@H](O)[C@H](NC(=O)[C@H](C)NC(=O)CN2CCOCC2)C(=O)N[C@@H](CC2=CCCC2)C(=O)[C@@]2(C)CO2)cc1","inchiKey":"GHYOCDFICYLMRF-UTIIJYGPSA-N","drugType":"Protein","blackBoxWarning":false,"name":"KZR-616","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KZR-616","Kzr-616","Zetomipzomib"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297706","drugType":"Unknown","blackBoxWarning":false,"name":"BMS-986179","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986179","BMS986179","Bms 986179","Bms-986179"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297739","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"DANVATIRSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD 9150","AZD-9150","AZD9150","Azd9150","Danvatirsen","ISIS-481464","ISIS-STAT3RX"],"linkedTargets":{"rows":["ENSG00000168610"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000182","EFO_0000403","EFO_0000181","EFO_0003060","EFO_0000311","MONDO_0001187"],"count":7},"description":"Oligonucleotide drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4297924","drugType":"Unknown","blackBoxWarning":false,"name":"POWDERED CELLULOSE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cellulose","E-460(II)","INS NO.460(II)","INS-460(II)","Powdered cellulose"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298180","drugType":"Cell","blackBoxWarning":false,"name":"DARVADSTROCEL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alofisel"],"synonyms":["CX-601","Cx601","Darvadstrocel"],"description":"Cell drug with a maximum clinical trial phase of IV (across all indications) and is indicated for immune system disease and has 1 investigational indication."}
{"id":"CHEMBL4298199","drugType":"Gene","blackBoxWarning":false,"name":"IDECABTAGENE VICLEUCEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-bcma car t cell","BB-2121","Ide-cel","Idecabtagene vicleucel","bb2121"],"linkedTargets":{"rows":["ENSG00000048462"],"count":1},"linkedDiseases":{"rows":["EFO_0001378"],"count":1},"description":"Gene drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4301898","canonicalSmiles":"CCOc1ccc(Nc2ccc(/C(=C3/C=C/C(=[N+](/CC)Cc4cccc(S(=O)(=O)[O-])c4)C=C3C)c3ccc(N(CC)Cc4cccc(S(=O)(=O)O)c4)cc3C)cc2)cc1","inchiKey":"YVNQAIFQFWTPLQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"E133","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["brilliant%20blue%20g"]},"childChemblIds":["CHEMBL4173394","CHEMBL423337"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2019."}
{"id":"CHEMBL431701","canonicalSmiles":"COc1cc([C@H]2Oc3cc([C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O)ccc3O[C@@H]2CO)ccc1O","inchiKey":"SEBFKMXJBCUCAI-HKTJVKLFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SILYBIN A","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-651520","Silibinin a","Silybin a","Silymarin","Silymarin i"],"crossReferences":{"PubChem":["144204621","144207953","170466469","17388738","50086851"],"drugbank":["DB09298"],"chEBI":["9144"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL435298","canonicalSmiles":"C[C@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1","inchiKey":"SYTBZMRGLBWNTM-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESFLURBIPROFEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BTS 24332","BTS-24332","Esflurbiprofen","Flurbiprofen, (s)-"],"crossReferences":{"PubChem":["47193727"],"chEBI":["42446"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["HP_0002829","HP_0003326","HP_0030839","EFO_0009582"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594260","canonicalSmiles":"Br.CCN(c1cc(-c2ccc(CN3CCOCC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1","inchiKey":"UQRICAQPWZSJNF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAZEMETOSTAT HYDROBROMIDE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3414621","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tazverik"],"synonyms":["E-7438 HYDROBROMIDE","EPZ-6438 HYDROBROMIDE","EPZ-6438 MONOHYDROBROMIDE","EZ-438","EZ438","Tazemetostat hydrobromide","Tazemetostat monohydrobromide"],"crossReferences":{"DailyMed":["tazemetostat%20hydrobromide"]},"linkedTargets":{"rows":["ENSG00000106462"],"count":1},"linkedDiseases":{"rows":["MONDO_0018906","EFO_0000691"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for follicular lymphoma and sarcoma."}
{"id":"CHEMBL4594326","drugType":"Antibody","blackBoxWarning":false,"name":"APITEGROMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apitegromab","SRK-015","Srk-015"],"linkedTargets":{"rows":["ENSG00000138379"],"count":1},"linkedDiseases":{"rows":["Orphanet_139547","Orphanet_83419","EFO_1000096"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4594396","canonicalSmiles":"Nc1ncnc2c1nc(Cl)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"MHDPPLULTMGBSI-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"8-CHLOROADENOSINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["8-chloroadenosine","NSC-354258"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594494","drugType":"Unknown","blackBoxWarning":false,"name":"SC-005","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Antibody-drug conjugate sc-005","SC-005","SC005","Sc-005"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4647810","canonicalSmiles":"C[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3ccn[nH]3)c2n1","inchiKey":"YBXRSCXGRPSTMW-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELIMUSERTIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-1895344","Elimusertib"],"linkedTargets":{"rows":["ENSG00000175054"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0024880"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4650319","canonicalSmiles":"C=CC(=O)Nc1cc(Nc2ncc(C(=O)OC(C)C)c(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C","inchiKey":"AZSRSNUQCUDCGG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MOBOCERTINIB","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AP-32788","AP32788","Mobocertinib","TAK-788","Tak-788"],"childChemblIds":["CHEMBL4802239"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0001421","EFO_0003060"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for non-small cell lung carcinoma and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4650330","canonicalSmiles":"Cc1ccn(-c2nc(NC3CCC(F)(F)CC3)cc(N3CCOCC3)n2)n1","inchiKey":"OVLIDRAJVMUEMC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIMTUZALCAP","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CAD-1883","Cad-1883","Rimtuzalcap"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650475","drugType":"Unknown","blackBoxWarning":false,"name":"IMM-0306","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMM-0306","IMM0306","Imm-0306","Imm0306"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4802143","canonicalSmiles":"CC(O)(P(=O)(O)O)P(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@@H](O)[C@@H]1O","inchiKey":"HUIKCRXUQCSUJS-ZLRZYOKSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MBC-11","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mbc-11"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4802171","drugType":"Protein","blackBoxWarning":false,"name":"ENSOVIBEP","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ensovibep","MP-0420","MP0420","Mp0420"],"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4802211","drugType":"Unknown","blackBoxWarning":false,"name":"M-4076","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["M-4076","M4076"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL485","canonicalSmiles":"COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314","inchiKey":"OROGSEYTTFOCAN-DNJOTXNNSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CODEINE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Codeine","Codeine monohydrate","Codeinum","Codeinum monohydricum","Dea no. 9050","IDS-NC-005(SECT.-2)"],"crossReferences":{"DailyMed":["codeine%20phosphate","codeine%20polistirex","codeine%20sulfate"],"PubChem":["144207280"],"Wikipedia":["Codeine"],"drugbank":["DB00318"],"chEBI":["16714"]},"childChemblIds":["CHEMBL4297091","CHEMBL1257022","CHEMBL284671","CHEMBL1159819","CHEMBL369475","CHEMBL1201463","CHEMBL1201099"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["HP_0012532","HP_0012735","Orphanet_232","HP_0000545","EFO_0010072","HP_0000175","HP_0003394","EFO_0003843","EFO_0000546","MONDO_0005277","EFO_0003890","EFO_1001216","EFO_0010282","HP_0030833","EFO_0000764","MONDO_0005178","HP_0002019"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and has 5 approved and 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL504805","canonicalSmiles":"Cc1ccn(-c2cccc(C(F)(F)F)c2)c(=O)c1-c1ccc2nc(N)ncc2c1","inchiKey":"HXUZQEYFKAZBPX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL504805","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07528"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL509924","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO","inchiKey":"OGPWIDANBSLJPC-RFPWEZLHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFLUCORTOLONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nerisone","Nerisone fte","Temetex"],"synonyms":["BAY-866146","BAY866146","Diflucortolone","Diflucortolone 21-valerate","Diflucortolone valerate"],"crossReferences":{"drugbank":["DB09095"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL528","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=CCS[C@H]12)c1csc(N)n1","inchiKey":"NNULBSISHYWZJU-LLKWHZGFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTIZOXIME","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefizox","Ceftizoxime","FK-749"],"crossReferences":{"Wikipedia":["Ceftizoxime"],"drugbank":["DB01332"],"chEBI":["553473"]},"childChemblIds":["CHEMBL1201019"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL533","canonicalSmiles":"CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1","inchiKey":"ALOBUEHUHMBRLE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IBUTILIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ibutilide"],"crossReferences":{"DailyMed":["ibutilide%20fumarate"],"Wikipedia":["Ibutilide"],"drugbank":["DB00308"],"chEBI":["5856"]},"childChemblIds":["CHEMBL3187455","CHEMBL2355456"],"linkedTargets":{"rows":["ENSG00000055118"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0004269","HP_0001657"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1995 and is indicated for cardiac arrhythmia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL544","canonicalSmiles":"COc1ccc(O)cc1","inchiKey":"NWVVVBRKAWDGAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEQUINOL","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["4-hydroxyanisole","4-methoxyphenol","4ha","BMS-181158","Hqmme; hydroxyquinone methyl ether","Leucobasal","Leucodine b","Mechinolum","Menthyl anthranilate","Mequinol","NSC-4960","Novo-dermoquinona","P-guaiacol","P-hydroxyanisole"],"crossReferences":{"PubChem":["144204676","144209565","144213193","170464687","17389832","50105587","71152","85272557"],"Wikipedia":["Mequinol"],"drugbank":["DB09516"],"chEBI":["69441"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1999."}
{"id":"CHEMBL548","canonicalSmiles":"CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\\CCCC(=O)O","inchiKey":"XEYBRNLFEZDVAW-ARSRFYASSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DINOPROSTONE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cervidil","Prepidil","Propess","Prostin e2"],"synonyms":["Dinoprostone","Dinoprostone beta-cyclodextrin clathrate","Enzaprost e","Minprostin e2","NSC-165560","NSC-196514","Prostaglandin e2","U-12,062","U-12062"],"crossReferences":{"DailyMed":["dinoprostone"],"PubChem":["144204747","170465000","26753268","26753269","26753270","50105679"],"Wikipedia":["Prostaglandin_E2"],"drugbank":["DB00917"],"chEBI":["15551"]},"linkedTargets":{"rows":["ENSG00000050628","ENSG00000160951","ENSG00000125384","ENSG00000171522"],"count":4},"linkedDiseases":{"rows":["HP_0001788","EFO_0003843","EFO_0002950"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 2 investigational indications."}
{"id":"CHEMBL588","canonicalSmiles":"Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1","inchiKey":"TVURRHSHRRELCG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOLDOPAM","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Carlacor","Fenoldopam","SK&F-82526","SK-82526"],"crossReferences":{"DailyMed":["fenoldopam%20mesylate"],"PubChem":["104171160","144203703","170465321","26752227","50104923","90340762"],"Wikipedia":["Fenoldopam"],"drugbank":["DB00800"],"chEBI":["5002"]},"childChemblIds":["CHEMBL1256646","CHEMBL1026"],"linkedTargets":{"rows":["ENSG00000184845"],"count":1},"linkedDiseases":{"rows":["HP_0001919","EFO_0001645","EFO_0000319","EFO_1002048","EFO_0000537"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for cardiovascular disease and hypertension and has 4 investigational indications."}
{"id":"CHEMBL605","canonicalSmiles":"CCN(CC)CCNC(=O)c1ccc(N)cc1.Cl","inchiKey":"ABTXGJFUQRCPNH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROCAINAMIDE HYDROCHLORIDE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL640","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Biocoryl","Novocainamid","Procainamide hydrochloride","Procan","Procan sr","Procanbid","Procapan","Pronestyl","Pronestyl-sr"],"synonyms":["Amidoprocaine","Cardiorytmin","NSC-757279","Procainamide HCl","Procainamide hcl","Procainamide hydrochloride","Procainamidi hydrochloridum"],"crossReferences":{"DailyMed":["procainamide%20hydrochloride"],"PubChem":["144210053","26747643","50106886","56423113","855728"],"chEBI":["8429"]},"linkedTargets":{"rows":["ENSG00000153253","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0004269","EFO_0000275","EFO_0003144","HP_0004308"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and is indicated for cardiac arrhythmia and ventricular arrhythmia and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL61","canonicalSmiles":"COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC","inchiKey":"YJGVMLPVUAXIQN-XVVDYKMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PODOFILOX","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Condyline","Condylox","Podofilox","Warticon"],"synonyms":["NSC-24818","Podofilox","Podophyllotoxin"],"crossReferences":{"DailyMed":["podofilox"],"PubChem":["144204425","144210120","170464788","26751475","26751476","29215001","50103982","50103983","56422495","56463668","855658","86163"],"Wikipedia":["Podophyllotoxin"],"drugbank":["DB01179"],"chEBI":["50305"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and has 3 approved indications."}
{"id":"CHEMBL654","canonicalSmiles":"CN1CCN2c3ncccc3Cc3ccccc3C2C1","inchiKey":"RONZAEMNMFQXRA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MIRTAZAPINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mirtazapine","Remeron","Remeron soltab","Zispin"],"synonyms":["6-azamianserin","Avanza","Mirataz","Mirtazapin","Mirtazapine","Mirtazapine anhydrous","Norset","ORG 3770","ORG-3770","Promyrtil","Rexer"],"crossReferences":{"DailyMed":["mirtazapine"],"PubChem":["144204516","29215050","49648465"],"Wikipedia":["Mirtazapine"],"drugbank":["DB00370"],"chEBI":["6950"]},"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000102468","ENSG00000150594","ENSG00000147246"],"count":5},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0004240","EFO_0002610","EFO_0005687","MONDO_0002009","HP_0000726","HP_0001824","EFO_0004698","EFO_0000289","MONDO_0002050","EFO_0000326","EFO_0003761","EFO_0004701","MONDO_0007079","EFO_0005230","EFO_0004215","EFO_0003756","EFO_0006911","HP_0002039","EFO_0001358","HP_0002315","EFO_0008533","HP_0000713","EFO_0003890","MONDO_0002491","HP_0004326","EFO_0004888","EFO_0007634","EFO_0003918"],"count":29},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 4 approved and 18 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL738","canonicalSmiles":"CCCC(C)C1(CC)C(=O)N=C([S-])NC1=O.[Na+]","inchiKey":"AWLILQARPMWUHA-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOPENTAL SODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL441","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Intraval","Intraval sod","Penthiobarbital","Pentothal","Thiomebumal","Thionembutal","Thiopentone","Trapanal"],"synonyms":["Farmotal","Hypnostan","Leopental","NSC-759557","Nesdonal","Penthiobarbital sodium","Ravonal","Sodium pentothal","Sodium thiopental","Thiomebumal sodium","Thiopental Sodium","Thiopental sodium","Thiopentalum natricum","Thiopentobarbitone sodium","Thiopentone","Thiopentone sodium","Trapanal"],"crossReferences":{"PubChem":["144205294","170464734","26749790"],"Wikipedia":["Sodium_thiopental"],"chEBI":["9561"]},"linkedTargets":{"rows":["ENSG00000145864","ENSG00000166206","ENSG00000163288"],"count":3},"linkedDiseases":{"rows":["EFO_0001645","EFO_1001454"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL810","canonicalSmiles":"Cn1nnc2c(C(N)=O)ncn2c1=O","inchiKey":"BPEGJWRSRHCHSN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TEMOZOLOMIDE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Temodal","Temodar","Temomedac","Temozolomide"],"synonyms":["CCRG-81045","M&B 39831","M&B-39831","M-39831","Methazolastone","Mk-7365","NSC-362856","SCH 52365","SCH-52365","Temozolomide"],"crossReferences":{"DailyMed":["temozolomide"],"PubChem":["170464968","174007391","26719845","465959","50112683","99355753"],"Wikipedia":["Temozolomide"],"drugbank":["DB00853"],"chEBI":["72564"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 3 approved and 70 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL861","canonicalSmiles":"CCC1(c2ccccc2)NC(=O)N(C)C1=O","inchiKey":"GMHKMTDVRCWUDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPHENYTOIN","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mesantoin"],"synonyms":["Mephenytoin","Methoin","NSC-34652"],"crossReferences":{"PubChem":["56463168"],"Wikipedia":["Mephenytoin"],"drugbank":["DB00532"]},"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0000474"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1946 and is indicated for epilepsy."}
{"id":"CHEMBL92404","canonicalSmiles":"C[C@H](O)[C@@H](CCOc1ccc2ccccc2c1)n1cnc(C(N)=O)c1","inchiKey":"UYAJDVNLQJVRHD-SCLBCKFNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL92404","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07785"]},"childChemblIds":["CHEMBL544550"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL939","canonicalSmiles":"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1","inchiKey":"XGALLCVXEZPNRQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEFITINIB","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Iressa"],"synonyms":["Gefitinib","Iressa","NSC-759856","ZD-1839","ZD1839"],"crossReferences":{"DailyMed":["gefitinib"],"PubChem":["103905343","103905344","124892204","124892206","137275808","144205236","170464828","29215403","50100103"],"Wikipedia":["Gefitinib"],"drugbank":["DB00317"],"chEBI":["49668"]},"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003859","MONDO_0004192","MONDO_0021117","EFO_0000571","EFO_0000681","EFO_1001465","MONDO_0007254","EFO_0001071","EFO_0000708","EFO_0004252","MONDO_0002087","EFO_0000308","MONDO_0020654","EFO_1001951","MONDO_0001187","EFO_1001480","MONDO_0002158","EFO_0000178","EFO_0000588","MONDO_0002974","MONDO_0002898","MONDO_0008903","EFO_1000251","EFO_0000182","EFO_0000196","EFO_0000514","EFO_0000707","EFO_1000158","EFO_0000616","EFO_0002618","EFO_0003897","EFO_0006859","MONDO_0008170","MONDO_0004669","MONDO_0007576","EFO_0000222","EFO_0000313","EFO_0003060","MONDO_0008315","EFO_0000621","EFO_0000311","EFO_0009260","EFO_0006861","EFO_1001100","EFO_0004284","EFO_0000233","EFO_0000702","MONDO_0002367","MONDO_0024880","EFO_0000691","EFO_0000519","EFO_0000181"],"count":53},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 3 approved and 45 investigational indications."}
{"id":"CHEMBL9514","canonicalSmiles":"COC(=O)Nc1nc2ccc(C(=O)c3cccs3)cc2[nH]1","inchiKey":"KYRVNWMVYQXFEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOCODAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-238159","Nocodazole","R 17,934","R-17934"],"crossReferences":{"PubChem":["104171185","11111427","11111428","11113976","124880639","124880641","124880643","134122","144203740","170466087","26747163","26752117","26752118","46500439","49667696","50104774","85231125","90341042"],"Wikipedia":["Nocodazole"],"drugbank":["DB08313"],"chEBI":["34892"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
